BANGALORE, India, Sept. 23, 2022 /PRNewswire/ -- The Hemostats market is segmented by Type - Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, by Application - Prehospital Treatment, Hospital Treatment. Global Opportunity Analysis and Industry Forecast, 2021 - 2028. It is published in Valuates Reports under the Medical Devices & Equipment Category.
The global Hemostats market size is estimated to be worth USD 2921.3 million in 2022 and is forecast to be a readjusted size of USD 4120.4 million by 2028 with a CAGR of 5.9% during the review period.
Major Factors Driving The Growth Of The Hemostats Market are
The rising emphasis on blood loss management during surgeries, the growing number of chronic illnesses, the efficacy of thrombin-based hemostats, and technical advancements will fuel the growth of the market.
Browse The Table of Contents And List of Figures At https://reports.valuates.com/market-reports/QYRE-Auto-10E596/global-hemostats
TRENDS INFLUENCING THE GROWTH OF THE GLOBAL HEMOSTATS MARKET
Hemorrhage is the main cause of military and civilian deaths. In emergency situations, uncontrolled hemorrhage causes over 30% of traumatic deaths, and excessive bleeding is the main reason for military casualties. Hemostatic agents prove to be effective in hospitals and can save lives in high-stress conditions. This will fuel the growth of the hemostats market. The agents prevent deaths related to hypothermia, infections, multiple organ failure, and acidosis. It is an important step in trauma treatment.
The rising prevalence of cardiovascular ailments and chronic diseases such as cancer is leading to growing surgical procedures. Healthcare infrastructure is expanding around the world to meet the rising demand for surgical processes. The hemostats market is driven by the extensive use of the products in preventing complicated bleeding during surgeries to keep the patient out of harm's way.
As per studies and research analysis, thrombin-based hemostatic agents applied before wound closure reduced postoperative blood loss and transfusion rate. There are no risks of infection, deep vein thrombosis, or occurrence of other complications. It is the primary agent used during knee arthroplasty surgeries. The agent can be stored at room temperature easily. Such beneficial properties will bolster the demand for the global hemostats market. The efficiency of a thrombin hemostat can be improved further by the use of a porcine gelatin sponge which facilitates direct pressure application.
Invasive medical procedures and surgeries are prone to excessive blood loss and organ failures. The need for effective blood control management is leading to the use of polysaccharide hemostatic systems, in turn, driving the growth of the global hemostats market. The blood loss is stopped by using non- anatomical and sensitive structures. Patients who have hemostatic abnormalities, high bone density, and arthritic disorders benefit the most from the use of these systems.
Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-10E596/Global_Hemostats_Market
HEMOSTATS MARKET SHARE ANALYSIS
Based on product type, the thrombin-based hemostats will witness significant growth with a market share of 40%.
Based on application, hospital treatment will dominate the hemostats market share due to the rising number of surgical procedures being performed and growing cases of chronic disorders.
Based on region, North America will grow the highest with a market share of 35%. This is due to the increasing number of surgeries, the strong presence of key players, and the rising geriatric population. On the other hand, Europe and China are the second largest with a total share of 35%.
Inquire For Customization : https://reports.valuates.com/request/customisation/QYRE-Auto-10E596/Global_Hemostats_Market
Market By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-10E596/Global_Hemostats_Market
Key players
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
Inquire For Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-10E596/Global_Hemostats_Market
Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-10E596&lic=single-user
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
SIMILAR REPORTS
- The global Hemostasis Products market size is estimated to be worth USD 6490.5 million in 2022 and is forecast to a readjusted size of USD 7584.5 million by 2028 with a CAGR of 2.6% during the review period.
- The global Hemostatis and Tissue Sealing Agents market size is estimated to be worth USD 3384 million in 2022 and is forecast to a readjusted size of USD 4800.3 million by 2028 with a CAGR of 6.0% during the review period.
- The global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size is projected to reach USD 7112.9 million by 2028, from USD 4263.9 million in 2021, at a CAGR of 7.1% during 2022-2028.
-Global Topical Absorbable Hemostats Market Insights, Forecast to 2028
- The global Medical Hemostatic Agents market was valued at USD 3313.2 million in 2020 and is expected to reach USD 4798.8 million by the end of 2027, growing at a CAGR of 5.4% during 2021-2027.
-Global Wound Closure Surgical Products Market Insights and Forecast to 2028
- The global Hemostat Powder market size is estimated to be worth USD 405.7 million in 2022 and is forecast to a readjusted size of USD 531.4 million by 2028 with a CAGR of 4.6% during the review period.
-Global Flowable Hemostats Market Insights, Forecast to 2028
-Global Adjunctive Hemostats Market Research Report 2022
- The global digital polymerase chain reaction market generated USD 508.8 million in 2020 and is projected to reach USD 1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.
- The global antimicrobial susceptibility testing market size was valued at USD 3040.00 million in 2020 and is projected to reach USD 4736.03 million by 2030 registering a CAGR of 5.8% from 2021 to 2030.
- The global Neurostimulation Devices market size is estimated to be worth USD 7454.1 million in 2022 and is forecast to a readjusted size of USD 14170 million by 2028 with a CAGR of 11.3% during the review period.
- The global Hip Replacement market size is projected to reach USD 2688.1 million by 2028, from USD 2257.7 million in 2021, at a CAGR of 2.5% during 2022-2028.
- The global Hip and Knee Replacement market was valued at USD 18790 million in 2020 and is expected to reach USD 24720 million by the end of 2027, growing at a CAGR of 4.0% during 2021-2027.
- The global Hip Replacement Devices market size is estimated to be worth USD 6277.7 million in 2022 and is forecast to be a readjusted size of USD 7335.8 million by 2028 with a CAGR of 2.6% during the review period.
- The global Orthopedic Devices market size is projected to reach USD 43250 million by 2027, from USD 34190 million in 2020, at a CAGR of 3.0% during 2021-2027.
- The global Orthopedic Prosthetics market size is estimated to be worth USD 1528.6 million in 2022 and is forecast to be a readjusted size of USD 2107.7 million by 2028 with a CAGR of 5.5% during the review period.
- The global Optometry Equipment market size is estimated to be worth USD 2224 million in 2022 and is forecast to be a readjusted size of USD 2686.7 million by 2028 with a CAGR of 3.2% during the forecast period.
- The global Hemodialysis market size is estimated to be worth USD 2018.1 million in 2022 and is forecasted to reach USD 2206.7 million by 2028 with a CAGR of 1.5% during the review period.
- The global dialysis market size was valued at USD 91,205.0 million in 2020 and is estimated to reach USD 129,756.8 million by 2028, registering a CAGR of 4.7% from 2021 to 2028.
- The global Hemodialysis and Peritoneal Dialysis market size is projected to reach USD 118800 million by 2028, from USD 86390 million in 2021, at a CAGR of 4.6% during 2022-2028.
- The global Peritoneal Dialysis market size is estimated to be worth USD 125.2 million in 2021. It is forecast to be a readjusted size of USD 190.4 million by 2028 with a CAGR of 6.1% during the forecast period 2022-2028.
- The global Digital PCR (DPCR) and QPCR market size is estimated to be worth USD 1419.2 million in 2022 and is forecast to be a readjusted size of USD 2165.8 million by 2028 with a CAGR of 7.3% during the review period.
- The global Disposable Medical Supplies market size is projected to reach USD 314410 Million by 2028, from USD 224050 Million in 2021, at a CAGR of 4.9% during 2022-2028.
- The global Sterilization Equipment market was valued at USD 1674.3 million in 2022 and is expected to reach USD 2005.8 million by the end of 2028, growing at a CAGR of 3.06% from 2022 to 2028.
- The global Medical Tubing market size is estimated to be worth USD 8136.6 million in 2022 and is forecast to be a readjusted size of USD 13570 million by 2028 with a CAGR of 8.9% during the review period.
- The global Medical Supplies market size is projected to reach USD 329030 million by 2028, from USD 202430 million in 2021, at a CAGR of 7.1% during 2022-2028.
- The global digital therapeutics market size was valued at USD 2.88 Billion in 2019 and is expected to reach USD 13.80 Billion by 2027 with a CAGR of 20.5% during the forecast period.
- The global Physiotherapy Equipment market size is estimated to be worth USD 13610 million in 2022 and is forecast to be a readjusted size of USD 16530 million by 2028 with a CAGR of 3.3% during the review period.
- The global Nutritional Analysis market size is projected to reach USD 4733.1 million by 2027, from USD 3360 million in 2020, at a CAGR of 5.0% during 2021-2027.
- The global Biometrics market size is projected to reach USD 39030 million by 2028, from USD 15900 million in 2021, at a CAGR of 13.2% during 2022-2028.
- The global full body scanner market size is estimated to be worth USD 917.8 million in 2022 and is projected to reach USD 2541.4 million by 2028 with a CAGR of 18.5% during the forecast period.
- The global Fiducial Markers market size is estimated to be worth USD 104.8 million in 2022 and is forecast to be a readjusted size of USD 131.4 million by 2028 with a CAGR of 3.9% during the review period.
Click Here To See Related Reports on Hemostats Market
About Us:
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
Contact Us:
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/hemostats-market-will-reach-usd-4120-4-million-by-2028-with-a-cagr-of-5-9---valuates-reports-301632009.html
